Nichole Tanner to Male
This is a "connection" page, showing publications Nichole Tanner has written about Male.
Connection Strength
0.800
-
An Evaluation of Annual Adherence to Lung Cancer Screening in a Large National Cohort. Am J Prev Med. 2022 08; 63(2):e59-e64.
Score: 0.043
-
Mediastinal Staging for Lung Cancer. Chest. 2021 10; 160(4):1552-1559.
Score: 0.040
-
Assessment of Integrated Classifier's Ability to Distinguish Benign From Malignant Lung Nodules: Extended Analyses and 2-Year Follow-Up Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial. Chest. 2021 03; 159(3):1283-1287.
Score: 0.039
-
Association of Cigarette Type and Nicotine Dependence in Patients Presenting for Lung Cancer Screening. Chest. 2020 11; 158(5):2184-2191.
Score: 0.038
-
Screening Adherence in the Veterans Administration Lung Cancer Screening Demonstration Project. Chest. 2020 10; 158(4):1742-1752.
Score: 0.038
-
Association of Cigarette Type With Lung Cancer Incidence and Mortality: Secondary Analysis of the National Lung Screening Trial. JAMA Intern Med. 2019 12 01; 179(12):1710-1712.
Score: 0.036
-
Effect of a Rule-in Biomarker Test on Pulmonary Nodule Management: A Survey of Pulmonologists and Thoracic Surgeons. Clin Lung Cancer. 2020 03; 21(2):e89-e98.
Score: 0.035
-
Standard Bronchoscopy With Fluoroscopy vs Thin Bronchoscopy and Radial Endobronchial Ultrasound for Biopsy of Pulmonary Lesions: A Multicenter, Prospective, Randomized Trial. Chest. 2018 11; 154(5):1035-1043.
Score: 0.033
-
Reviewing Lung Cancer Screening: The Who, Where, When, Why, and How. Clin Chest Med. 2018 03; 39(1):31-43.
Score: 0.032
-
Assessing the Generalizability of the National Lung Screening Trial: Comparison of Patients with Stage 1 Disease. Am J Respir Crit Care Med. 2017 09 01; 196(5):602-608.
Score: 0.031
-
Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation. Chest. 2017 08; 152(2):263-270.
Score: 0.030
-
Primary Care Provider and Patient Perspectives on Lung Cancer Screening. A Qualitative Study. Ann Am Thorac Soc. 2016 11; 13(11):1977-1982.
Score: 0.029
-
The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial. Am J Respir Crit Care Med. 2016 Mar 01; 193(5):534-41.
Score: 0.028
-
Management of Pulmonary Nodules by Community Pulmonologists: A Multicenter Observational Study. Chest. 2015 Dec; 148(6):1405-1414.
Score: 0.028
-
What's in a Number? When It Comes to Pulmonary Nodules, It's All About the Number. Am J Respir Crit Care Med. 2015 Nov 15; 192(10):1149-50.
Score: 0.028
-
Racial Differences in Outcomes within the National Lung Screening Trial. Implications for Widespread Implementation. Am J Respir Crit Care Med. 2015 Jul 15; 192(2):200-8.
Score: 0.027
-
Screening for Lung Cancer Using Low-Dose Computed Tomography. Are We Headed for DANTE's Paradise or Inferno? Am J Respir Crit Care Med. 2015 May 15; 191(10):1100-1.
Score: 0.027
-
Attitudes and beliefs toward lung cancer screening among US Veterans. Chest. 2013 Dec; 144(6):1783-1787.
Score: 0.024
-
Simultaneously diagnosing and staging lung cancer: a win-win for the patient and the health-care system. Chest. 2013 Dec; 144(6):1747-1749.
Score: 0.024
-
Physician preferences for management of patients with stage IIIA NSCLC: impact of bulk of nodal disease on therapy selection. J Thorac Oncol. 2012 Feb; 7(2):365-9.
Score: 0.021
-
Characteristics of Persons Screened for Lung Cancer in the United States : A Cohort Study. Ann Intern Med. 2022 Nov; 175(11):1501-1505.
Score: 0.011
-
Factors Associated With Smoking Cessation Attempts in Lung Cancer Screening: A Secondary Analysis of the National Lung Screening Trial. Chest. 2023 02; 163(2):433-443.
Score: 0.011
-
Occurrence of Discussion about Lung Cancer Screening Between Patients and Healthcare Providers in the USA, 2017. J Cancer Educ. 2020 08; 35(4):678-681.
Score: 0.010
-
An Evaluation of Diagnostic Yield From Bronchoscopy: The Impact of Clinical/Radiographic Factors, Procedure Type, and Degree of Suspicion for Cancer. Chest. 2020 06; 157(6):1656-1664.
Score: 0.009
-
Safety and Efficacy of Remimazolam Compared With Placebo and Midazolam for?Moderate Sedation During Bronchoscopy. Chest. 2019 01; 155(1):137-146.
Score: 0.008
-
Incorporating Coexisting Chronic Illness into Decisions about Patient Selection for Lung Cancer Screening. An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2018 07 15; 198(2):e3-e13.
Score: 0.008
-
Tobacco Dependence Predicts Higher Lung Cancer and Mortality Rates and Lower Rates of Smoking Cessation in the National Lung Screening Trial. Chest. 2018 07; 154(1):110-118.
Score: 0.008
-
Comparison of Observed Harms and Expected Mortality Benefit for Persons in the Veterans Health Affairs Lung Cancer Screening Demonstration Project. JAMA Intern Med. 2018 03 01; 178(3):426-428.
Score: 0.008
-
Assessment of Plasma Proteomics Biomarker's Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial. Chest. 2018 09; 154(3):491-500.
Score: 0.008
-
Comparing Pulmonary Nodule Location During Electromagnetic Bronchoscopy With Predicted Location on the Basis of Two Virtual Airway Maps at Different Phases of?Respiration. Chest. 2018 01; 153(1):181-186.
Score: 0.008
-
Racial and Ethnic Disparities in Early-Stage Lung Cancer Survival. Chest. 2017 09; 152(3):587-597.
Score: 0.008
-
Implementation of Lung Cancer Screening in the Veterans Health Administration. JAMA Intern Med. 2017 03 01; 177(3):399-406.
Score: 0.008
-
Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial. Ann Am Thorac Soc. 2016 09; 13(9):1568-74.
Score: 0.007
-
Reply: Lung Cancer Screening: The Balance between Harm and Benefit. Am J Respir Crit Care Med. 2015 May 15; 191(10):1209-10.
Score: 0.007
-
Lung cancer screening. Am J Respir Crit Care Med. 2015 Jan 01; 191(1):19-33.
Score: 0.006
-
Factors that influence physician decision making for indeterminate pulmonary nodules. Ann Am Thorac Soc. 2014 Dec; 11(10):1586-91.
Score: 0.006
-
Outcome of patients with negative and unsatisfactory cytologic specimens obtained by endobronchial ultrasound-guided transbronchial fine-needle aspiration of mediastinal lymph nodes. Cancer Cytopathol. 2015 Feb; 123(2):92-7.
Score: 0.006
-
Assessing the usefulness of 18F-fluorodeoxyglucose PET-CT scan after stereotactic body radiotherapy for early-stage non-small cell lung cancer. Chest. 2014 Aug; 146(2):406-411.
Score: 0.006
-
Response. Chest. 2014 Aug; 146(2):e70.
Score: 0.006
-
The utility of nodule volume in the context of malignancy prediction for small pulmonary nodules. Chest. 2014 Mar 01; 145(3):464-472.
Score: 0.006
-
The use of convex probe endobronchial ultrasound-guided transbronchial needle aspiration in a pediatric population: a multicenter study. Pediatr Pulmonol. 2014 Aug; 49(8):807-15.
Score: 0.006
-
Using endobronchial ultrasound features to predict lymph node metastasis in patients with lung cancer. Chest. 2011 Dec; 140(6):1550-1556.
Score: 0.005